DNA SEQ 2
Vista, US · Founded 2022 · Delaware corporation
Founders & leadership
AN
Andrew NappinExecutive
JM
Janusz Maria SowadskiNamed on SEC filing
Board
TM
Thomas M. WheelerBoard director
BA
Benjamin AndersonBoard director
SE
Stuart E. SiegelBoard director
EL
Eric LadizinskyBoard director
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 1 round · 2024
▶$1.2MraisedMar 2026 · 32 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedMar 2026 · 32 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas M. WheelerDirector
- Benjamin AndersonDirector
- Stuart E. SiegelDirector
- Janusz Maria SowadskiDirector
- Eric LadizinskyDirector
- Andrew NappinExecutive Officer
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has DNA SEQ 2 raised?
- DNA SEQ 2 has disclosed $1.2M raised across 1 round.
- Where is DNA SEQ 2 headquartered?
- DNA SEQ 2 is headquartered in Vista, US.